View original content: https://www.prnewswire.com/news-releases/labware-continues-to-provide-leadership-through-strategic-partnerships-and-innovation-in-irelands-biopharma-sector-302163156.html

WILMINGTON, Del., June 4, 2024 /PRNewswire/ -- LabWare, a global leader in Laboratory Information Management Systems (LIMS) within the Pharma and BioPharma industry, last month played a key role in spearheading and guiding an exploratory delegation led by the Governor of Delaware to investigate and exchange opportunities within Ireland's BioPharma sector. This visit focused on Ireland's success in biopharmaceutical manufacturing, fostering collaborations, exploring innovation, and leveraging valuable insights from LabWare. Other participants included the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) and the University of Delaware. 

Patrick Callahan, LabWare's Director of Analytics and Tom Brohan, LabWare's Ireland Service Delivery Manager, the sole industry participants, engaged with esteemed organizations, including Ireland's National Institute for Bioprocessing Research and Training (NiBRT,  the University of Limerick, Trinity College, regional economic development entities like IDA Ireland and The Science Foundation Ireland Research Centre for Pharmaceuticals (SSPC) and several of LabWare's BioPharma clients including Astra Zeneca. 

During the delegation visit, key observations were made: 

• Advancements in Ireland's Biopharmaceutical Manufacturing: Substantial investments in workforce development, government incentives, and robust collaboration between government, industry, and academia have all contributed to their progress.
• Growth in BioPharma Manufacturing and Research and Development: Ireland's trajectory in Manufacturing and R&D, backed by venture capital and state-of-the-art facilities, presents significant opportunities.
• Technology Companies' Interest: Major tech players like Amazon, Microsoft, and Google are intensifying their focus on Ireland's BioPharma sector, indicating a conducive environment for innovation.
• Commitment to Science Education: Ireland's early investment in science education nurtures a skilled workforce and fosters collaborative research initiatives.

Patrick Callahan, representing LabWare, remarked, "Our engagement and leadership with Ireland's BioPharma sector has been key to our growth in the BioPharma industry. The commitment to innovation and collaboration we have witnessed aligns perfectly with LabWare's ethos of driving technological advancements in the biopharmaceutical industry and our investment in scientific education." 

LabWare identified numerous collaboration and expansion opportunities during the visit, reinforcing its commitment to advancing technology integration and strategic partnerships within the global biopharmaceutical landscape. 

This experience underscores LabWare's dedication to innovation and collaboration in driving the biopharmaceutical industry forward.  

"As an Ireland native and long-term employee of LabWare, I am proud to see the significance of software advancements in the Biopharmaceutical space and showcase what has transpired in our country.  We look at this as illuminating the path for future innovations in the U.S." says Tom Brohan, LabWare's Ireland representative.  

SEOUL, KOREA -- LabWare Korea Co., Ltd

LabWare is excited to announce the grand opening of our latest office, situated in the heart of Seoul, Korea.

LabWare는 대한민국 서울에 새로운 사무실의 개소를 알리게 되어 매우 기쁘게 생각합니다.

This expansion marks a significant stride forward in our global objective to provide world-leading, cutting-edge laboratory informatics solutions to customers across the globe.

이번 확장은 전 세계 고객들에게 선도적인 최첨단 실험실 정보 솔루션을 제공하려는 글로벌 목표에 한 걸음 더 나아가는 중요한 진전입니다.

Extending global coverage and complementing existing Asia Pacific Offices

Accompanying the inauguration of our Seoul Office and the establishment of LabWare Korea Co., Ltd, we are delighted to introduce our esteemed Korean Team, comprising seasoned LIMS professionals who bring a wealth of experience and local expertise to the table.

서울 사무소 개소 및 LabWare Korea Co., Ltd의 설립과 함께 풍부한 경험과 현지 전문 지식을 제공하는 숙련된 LIMS 전문가로 구성된 존경받는 한국 팀을 소개하게 되어 기쁩니다.
한국 팀은 실험실 정보 솔루션 분야에서 많은 경험을 가진 전문가들로 구성되어 있으며 한국 시장에 대한 깊은 이해와 기술적 노하우는 LIMS 고객들에게 보다 우수한 서비스를 제공할 수 있게 도와줄 것입니다.

Our Korean Office and Korean Team extend our global coverage and complement our existing Asia Pacific Offices and Teams who are located in Australia (Adelaide, Brisbane, Melbourne, Sydney), China (Beijing, Chengdu, Jinan, Nanjing, Shanghai), Indonesia (Jakarta), Japan (Tokyo), Malaysia (Kuala Lumpur), New Zealand (Auckland, Tauranga), Philippines (Manila), Singapore, Taiwan (Kaohsiung, Taipei), Thailand (Bangkok) and Vietnam (Ho Chi Minh City).

한국 지사와 한국 팀은 아시아 태평양 지사 및 팀을 보완하고 글로벌 서비스 범위를 확장합니다,
아시아 태평양 지사 및 팀은 호주 (애들레이드, 브리즈번, 멜버른, 시드니), 중국 (베이징, 청두, 진안, 난징, 상하이), 인도네시아(자카르타), 일본(도쿄), 말레이시아(쿠알라룸푸르), 뉴질랜드(오클랜드, 타우랑가), 필리핀(마닐라), 싱가포르, 대만(가오슝, 타이베이), 태국(방콕), 베트남(호치민)에 위치해 있습니다.

Visit the LabWare Korea Co., Ltd Office:

Seoul, Regus Gangnam Station Centre
16F, Gangnam Bldg
396 Seocho-daero, Seocho-gu
Seoul 06619, Korea
+82 (2) 2190 3764
Email: infoAP@labware.com

Lüneburg, DE / Delaware, US

LabWare® has achieved the “Ready” level required to join Körber's Ecosystem of partner companies.

With that, the two companies are taking the seamless integration capabilities between LabWare’s LIMS (Laboratory Information Management System) and Körber’s PAS-X MES (Manufacturing Execution System) to a new level of cooperation.

Körber's collaboration with LabWare marks the next milestone following the launch of Körber's "PAS-X LIMS Integration" program, a new element within the Körber Ecosystem. This program offers customers improved convenience in identifying LIMS suppliers compatible with PAS-X MES. It demonstrates to customers that Körber and its partners can significantly reduce the effort and risk involved in integrating LIMS with Körber's world-leading Manufacturing Execution System PAS-X MES by using a standardized interface. 

LabWare, a trusted partner to most of the top 25 global pharmaceutical companies and a worldwide leader in laboratory informatics, brings profound expertise and operational excellence to this relationship. “Our LIMS is used at more than 29,000 laboratories with more than 150,000 daily users and a billion samples tested a year,” says Mark Gonzalez, Technical Director at LabWare. As a certified partner, LabWare demonstrates seamless integration capabilities with PAS-X MES. “The successful collaboration between LabWare and Körber has already greatly benefited our shared customers over the years,” Gonzalez adds. 

The integration of MES and LIMS has emerged as a pivotal component in the digital transformation journey within the pharma and biopharma industry, especially given the laboratory's critical role in the overall production and supply chain processes. Lars Hornung, Senior Principal Alliances & Technology Partners Software, Körber Business Area Pharma, elaborates: “For instance, as part of the manufacturing process, PAS-X MES triggers a sample request to the LIMS, and the LIMS communicates detailed sample data back to the MES, enabling efficient label printing for each sample. After sample collection, PAS-X MES sends a sample confirmation to LIMS, including additional information for Quality Control (QC) purposes. The laboratory conducts the tests, and LIMS manages the results, which are then transmitted back to MES for further processing. Therefore, seamless integration between these systems is vital to streamlining processes and eliminating human error.”

WAGENINGEN, NL -- LabWare Nederland

LabWare® branches out to Wageningen, The Netherlands, expanding its network of over 40 offices that operate across 6 continents.

The branch in Wageningen focuses on the Benelux area (Belgium, The Netherlands, and Luxembourg), starting with a team of 6 individuals that is expected to double within the next 3 years.

A strategic choice for the advancement of scientific research and innovation

The global recognition of the Netherlands as a hub for research and innovation uniquely positions it to offer strong backing to a company such as LabWare, worldwide leader in automation and data management solutions for laboratories.

Historic and multicultural city in the central Netherlands, in the province of Gelderland, Wageningen is renowned for its University, specializing in life sciences, agriculture, technical and engineering subjects. Wageningen is therefore known also as “The city of life sciences”, with a leading position in these fields, as well as in health research and development, providing companies with both a customer base and a favorable environment for experimentation and innovation with a strong focus on sustainability.

Frank Hendriks, Territory Manager Benelux at LabWare, states: “When contemplating further expanding into Europe, we thoroughly assessed numerous potential locations, and Wageningen emerged as our top choice”. The region's strategic positioning, alongside cutting-edge infrastructure, and proximity to diverse research institutions, offers an optimal setting for fostering collaboration and innovation.

LabWare’s commitment to empower cross-sectoral sustainable solutions

LabWare promotes innovation and sustainable solutions within agriculture and food production by supporting research and development.

It is indeed LabWare’s mission to deliver laboratory automation, efficiency, data integrity, and compliance by means of informatics solutions. The LabWare laboratory automation suite allows to easily manage data, optimizing workflows and collaboration – which is vital for companies striving to develop and implement sustainable technologies.

With its new premises in Wageningen, in the Agro Business Park Garden Offices – where multiple innovative health companies are also situated – LabWare Nederland connects with relevant partners and networks, perfectly aligning with the regional focus on driving innovation and sustainable solutions for global challenges.

Visit the Wageningen Office:

Agro Business Park 2
Garden Offices
6708 PW
Wageningen, Netherlands

WILMINGTON, Del.-- LabWare, Inc., reinforcing it's position as the worldwide leader in enterprise laboratory automation software, today announced that it has been named "Leader" in the LIMS, ELN, and Lab Inventory Management Categories on G2's 2023 Reports.

Photo: via Yposkesi

ALTRINCHAM, UK-- LabWare Limited

Yposkesi, an SK pharmteco company, is one of Europe’s largest Contract Development and Manufacturing Organizations (CDMO) for gene therapy viral vector manufacturing, which, after a formal selection process of the leading LIMS solutions within the market, chose to implement LabWare as their LIMS solution for their Corbeil-Essonnes (France) site.

WILMINGTON, Del.-- LabWare, Inc., recognized worldwide as the leader in enterprise laboratory automation software, today announced that it has once again been ranked as a "Leader" in the LIMS Systems Category on G2's 2022 Summer Reports.

WILMINGTON, Del.-- LabWare Holdings today announced it has signed a definitive agreement to acquire CompassRed, a visionary company in machine learning and predictive analytics. The acquisition of CompassRed will create a new dedicated advanced data analytics arm in LabWare®, embedding the CompassRed solution into the core LabWare platform, and providing services that will further elevate LabWare’s position as the global leader in the Laboratory Information Management market. 

Note: This story was featured in the April 2021 edition of LABInsights and has been edited for clarity.

Denkavit recently expanded the functionality of its LIMS, adding options for inventory management, tracking consumption and ordering lab consumables. To facilitate these additions to an application the animal feed manufacturer has been using since 2014, Denkavit’s LIMS supplier adapted its existing inventory management template and added new, client-specific functionalities.

A recent New York Times article highlighted the manufacturing, testing, and distribution processes for the Pfizer-BioNTech Covid-19 messenger RNA (mRNA) based vaccine.

The careful execution, integration, and optimization of multiple steps are critical to the vaccine's safety, effectiveness, and efficient delivery. Pfizer's multifaceted vaccine process takes 60 days from start to finish across numerous locations involving thousands of employees. More than half of this effort goes to quality testing, which must adhere to vaccine manufacturing regulatory requirements, including compliance with current Good Manufacturing Practices (cGMP).

WILMINGTON, Del.-- LabWare, Inc., recognized worldwide as the leader in enterprise laboratory automation software, today announced that it has dominated the Laboratory Software Category in G2's 2021 Spring Grid Reports.

Effective utilization of LIMS KPI Dashboards is crucial for driving laboratory efficiency and streamlining processes. In this blog post, we will delve into the importance of key performance indicators (KPIs) in a lab setting, focusing on how they enhance accountability and can be customized to cater to specific requirements.